|Videos|June 27, 2023

DIA 2023: Cal Collins Discusses the Near-Term and Long-Term Future of SMART on FHIR

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the near-term and long-term future of SMART on FHIR.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?

ByPatrick Mizer,Andy Studna, Senior Editor

August 28th 2026

ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise

ByAndy Studna, Senior Editor

August 28th 2026

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

ByPatrick Mizer,Andy Studna, Senior Editor

August 27th 2026

Generative AI is moving faster than any technology shift in history—and sponsors and CROs that treat a powerful model as a strategy, rather than a governed, validated workflow, are gambling with patient safety and regulatory standing.

AI Is Moving Faster Than Any Technology Before It

August 27th 2026

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

ByAndy Studna, Senior Editor

August 27th 2026

Trending on Applied Clinical Trials Online

AI Is Moving Faster Than Any Technology Before It

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?